MTOR and hepatocellular carcinoma: In this study, we evaluated the expression MAPK pathway and PI3K/Akt/mTOR proteins in HCC and investigated their association with clinical and histopathological parameters and long-term outcomes, according to the etiology of the underlying CLD.